Lead Product(s) : IRL201805
Therapeutic Area : Immunology
Study Phase : Phase II
Sponsor : Revolo Biotherapeutics
Deal Size : Undisclosed
Deal Type : Agreement
Details : Under the terms of the agreement, Northway will provide the full scope of its’ services ranging from cell line development to batch production of ‘1805 Active Pharmaceutical Ingredients (API) and drug product, following Current Good Manufacturing Pra...
Product Name : IRL201805
Product Type : Antibody
Upfront Cash : Undisclosed
September 06, 2021
Lead Product(s) : IRL201805
Therapeutic Area : Immunology
Highest Development Status : Phase II
Sponsor : Revolo Biotherapeutics
Deal Size : Undisclosed
Deal Type : Agreement